Texas Sues Tylenol Makers Over Pregnancy Marketing

Texas Attorney General Files Landmark Suit Against Tylenol Producers

Texas Attorney General Ken Paxton has initiated legal action against the manufacturers of Tylenol, alleging deceptive marketing practices targeting pregnant individuals. The lawsuit contends that Johnson & Johnson, the original creators of the widely used pain reliever, and Kenvue, a spin-off company that has distributed Tylenol since 2023, promoted the medication to expectant parents despite purported links to autism and attention-deficit hyperactivity disorder (ADHD) in children.

The complaint was officially lodged on Tuesday in a Texas state court. Paxton, who is currently campaigning for a U.S. Senate seat, asserts that both corporations violated Texas consumer protection statutes by failing to adequately inform consumers about these alleged risks.

Allegations of Fraudulent Transfer and Consumer Deception

In addition to claims of consumer deception, Paxton’s office is also suing Johnson & Johnson for allegedly breaching the Texas Uniform Fraudulent Transfer Act. The attorney general’s press release stated that the company “fraudulently transferred liabilities arising from Tylenol” to Kenvue, raising questions about corporate restructuring and accountability.

“Big Pharma betrayed America by profiting off of pain and pushing pills regardless of the risks. These corporations lied for decades, knowingly endangering millions to line their pockets,” Paxton declared in a strongly worded press release, underscoring the gravity of the state’s accusations.

Texas stands as the inaugural state to file such a lawsuit. This legal move follows recent comments from the Trump administration last month, which suggested a risk of autism associated with acetaminophen, Tylenol’s active ingredient, despite a noted absence of new scientific evidence to support this assertion. The timing of the suit also coincides with former President Donald Trump’s recent warnings on Truth Social, advising pregnant individuals to avoid the over-the-counter drug unless “absolutely necessary” and recommending against giving Tylenol to children “for virtually any reason.”

Manufacturers Defend Tylenol’s Safety Profile

In response to Paxton’s lawsuit, Tylenol’s manufacturers have consistently defended the safety of their product. Kenvue issued a statement on Tuesday directly addressing the legal challenge.

“Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy,” Kenvue’s statement affirmed. The company further elaborated, “Without it, women face dangerous choices: suffer through conditions like fever that are potentially harmful to both mom and baby or use riskier alternatives.” This stance echoes a similar defense Kenvue provided in a previous statement from September, emphasizing the medication’s critical role in maternal health.

The lawsuit is poised to ignite a significant legal and public health debate regarding medication safety during pregnancy and the responsibilities of pharmaceutical companies in their marketing practices.

Source: The Guardian